Veru Inc. (VERU) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Veru reported revenue of $0, down 100.0% from $16.9M the year before. Net income was -$22.7M. Operating activities generated -$30.0M of cash, leaving -$30.0M of free cash flow. At fiscal year end, Veru held $29.8M in total assets against $11.5M in total liabilities, including $15.8M of cash and equivalents.
Open the full interactive Veru financials → Quarterly statements, key ratios, valuation history and price charts.
Veru Key Stats
| Share Price | $2.19 |
|---|---|
| Market Cap | $50.5M |
| Revenue YoY Growth | -100.0% |
| 52-Week Range | $2.09 – $4.43 |
| Shares Outstanding | 23.1 million (basic, 2026 Q3) |
Veru Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $42.6M | $61.3M | $39.4M | $16.3M | $16.9M | $0 |
| Cost of Goods Sold | $11.8M | $13.3M | $8.8M | $8.7M | $11.0M | — |
| Gross Profit | $30.8M | $47.9M | $30.6M | $7.6M | $5.9M | — |
| Operating Income | -$14.7M | $13.0M | -$83.2M | -$93.7M | -$36.9M | -$24.8M |
| Pre-Tax Income | -$20.1M | $4.3M | -$83.5M | -$92.6M | -$37.1M | -$22.7M |
| Income Tax | -$1.1M | -$3.1M | $236,397 | $480,206 | $725,101 | $0 |
| Net Income | -$19.0M | $7.4M | -$83.8M | -$93.1M | -$37.8M | -$22.7M |
| Diluted EPS | -$2.80 | $0.90 | -$10.50 | -$11.00 | — | — |
Veru Quarterly Results
| 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | $1.5M | -$5.3M | -$2.7M | -$7.0M |
Veru Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | — | — | — | — | $24.9M | $15.8M |
| Current Assets | $27.0M | $151.8M | $104.8M | $23.5M | $35.2M | $18.9M |
| Total Assets | $51.5M | $178.1M | $136.1M | $50.6M | $60.4M | $29.8M |
| Current Liabilities | $14.7M | $15.8M | $41.4M | $20.3M | $11.9M | $7.8M |
| Total Liabilities | $21.4M | $25.9M | $55.3M | $32.8M | $28.1M | $11.5M |
| Shareholders' Equity | $30.1M | $152.3M | $80.8M | $17.8M | $32.3M | $18.3M |
Veru Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$1.9M | -$15.6M | -$47.5M | -$88.0M | -$21.7M | -$30.0M |
| Cash From Investing | -$105,760 | $14.6M | $4.3M | $6.3M | $146,214 | $25.1M |
| Cash From Financing | $9.3M | $109.7M | $1.1M | $11.1M | $36.8M | -$4.2M |
| Free Cash Flow | -$2.0M | -$15.9M | -$48.2M | -$88.7M | -$21.8M | -$30.0M |
Figures from Veru's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Veru financials page for every line item.
Veru Company Profile
| Ticker | VERU |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Miami, Florida |
| Incorporated in | Wisconsin |
| Fiscal Year End | September 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0000863894 |
Frequently Asked Questions
What was Veru's revenue in fiscal 2025?
Veru (VERU) reported revenue of $0 for fiscal 2025.
What is Veru's annual revenue history?
Veru's annual revenue by fiscal year: 2020: $42.6M; 2021: $61.3M; 2022: $39.4M; 2023: $16.3M; 2024: $16.9M; 2025: $0.
What was Veru's net income in fiscal 2025?
Veru reported net income of -$22.7M for fiscal 2025.
How much free cash flow did Veru generate in fiscal 2025?
Veru generated -$30.0M of free cash flow in fiscal 2025.
What was Veru's revenue last quarter?
In its most recent reported quarter (2026 Q3), Veru reported revenue of $0.
How many shares of Veru are outstanding?
Veru reported a weighted average of 23.1 million basic shares outstanding in 2026 Q3.
What is Veru's market cap?
Based on its latest closing price, Veru (VERU) has a market capitalization of about $50.5M.
When does Veru's fiscal year end?
Veru's fiscal year end, as registered with the SEC, is September 30.
Where is Veru headquartered?
Veru lists its business address in Miami, Florida in its SEC filings.